Data as of May 17
| +0.20 / +7.12%|
The 6 analysts offering 12-month price forecasts for Aveo Pharmaceuticals Inc have a median target of 2.75, with a high estimate of 6.00 and a low estimate of 1.00. The median estimate represents a -8.64% decrease from the last price of 3.01.
The current consensus among 9 polled investment analysts is to Hold stock in Aveo Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.